MK-2225

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-2225, covering 2025-07-29 to 2025-07-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK-2225 in Healthy Participants (MK-2225-003) [Phase 1]